meta
|
Preg
- medecines during pregnancy KB
Search
Adalimumab
Overall results
Study description
Excluded studies
Table
Graphic
auto
during pregnancy (anytime or not specified)
1st trimester
2nd trimester
3rd trimester
2nd and/or 3rd trimester
throughout pregnancy
early pregnancy
days before delivery
late pregnancy
preconception-only
periconceptional
preconceptional for kinetic reason
at least 1st trimester
3 months (or more) before pregnancy or during pregnancy
1st and 2nd trimester
3 months or more before pregnancy or1st trimester
Whatever the period exposition
individual studies
Outcome
TE
95% CI
n cases
n exposed
k
Pub. bias
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)
Hyrich, 2006 Weber-Schoendorfer, 2015 Hoxha, 2017 Chambers (Controls, sick), 2019 De Lorenzo (Controls unexposed, sick), 2020
5
2.51
[
1.06
; 5.97]
62
380
not evaluable
Major congenital malformations
Hyrich, 2006 Weber-Schoendorfer, 2015 Hoxha, 2017 Chambers (Controls, sick), 2019
4
2.30
[
0.94
; 5.64]
62
378
not evaluable
Microcephaly / Small head circumference for gestational age
Chambers (Controls, sick), 2019
1
1.46
[
0.67
; 3.17]
39
182
not evaluable
Minor congenital malformations
Chambers (Controls, sick), 2019
1
0.59
[
0.31
; 1.12]
64
173
not evaluable
Growth parameters and prematurity
Preterm (< 37 weeks)
Hoxha, 2017 Chambers (Controls, sick), 2019 De Lorenzo (Controls unexposed, sick), 2020
3
1.17
[
0.40
; 3.41]
42
220
not evaluable
Small for gestational age (weight)
Chambers (Controls, sick), 2019 De Lorenzo (Controls unexposed, sick), 2020
2
0.80
[
0.40
; 1.61]
30
208
not evaluable
Macrosomia (> 4000g)
De Lorenzo (Controls unexposed, sick), 2020
1
21.00
[
0.30
; 1469.95]
-
2
not evaluable
Small for gestational age (length)
Chambers (Controls, sick), 2019
1
1.05
[
0.41
; 2.68]
19
205
not evaluable
Maternal consequences
Caesarean
0
-
-
-
-
-
Maternal consequences (as a whole)
Hoxha, 2017
1
9.00
[
0.29
; 275.58]
1
5
not evaluable
Neonatal disorders
Neonatal infections
Vinet (Unexposed controls, sick), 2018 Chambers (Controls, sick), 2019
2
0.96
[
0.41
; 2.23]
66
337
not evaluable
Long term consequences
Cancer (all kind) in children or adults
Chambers (Controls, sick), 2019
1
0.48
[
0.01
; 24.53]
-
229
not evaluable
Child/Infant head circumference abnormalities (> 1 year)
Chambers (Controls, sick), 2019
1
2.10
[
0.42
; 10.45]
11
161
not evaluable
Child/Infant weight abnormalities (> 1 year)
Chambers (Controls, sick), 2019
1
1.17
[
0.54
; 2.52]
41
168
not evaluable
Intrauterine deaths
Early intrauterine death (< 22 weeks)
Hyrich, 2006 Chambers (Controls, sick), 2019
2
2.39
[
0.78
; 7.30]
32
260
not evaluable
Elective/induced termination of pregnancy
Hyrich, 2006 Chambers (Controls, sick), 2019
2
1.95
[
0.15
; 24.78]
1
260
not evaluable
Late intrauterine deaths (> 22 weeks)
Chambers (Controls, sick), 2019
1
0.47
[
0.01
; 23.62]
-
257
not evaluable
Intrauterine deaths (as a whole or unspecified)
Hoxha, 2017
1
0.24
[
0.01
; 5.76]
3
5
not evaluable
Therapeutic terminations of pregnancy
0
-
-
-
-
-
0.0
100.0
1.0